Six years after a spectacular debut, Warp Drive Bio is powering down and handing its 'undruggable' ambitions over to Revolution
Close to six years after Third Rock launched Warp Drive Bio with a big-money collaboration from Sanofi and ambitious plans to drug the undruggable with new tech out of Harvard, the biotech has reached the end of the line as an independent operation.
Today Warp Drive is dispatching its pipeline to another Third Rock startup company, Revolution Medicines, with the CEOs of both companies insisting that this is a win-win for all involved, though Warp Drive never actually made the leap into the clinic.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.